Robatumumab, CAS 934235-44-6

Product Description: Robatumumab (Sch 717454) is an anti-human IGF-1R (insulin-like growth factor receptor-1) antibody. Robatumumab shows anti-tumor activity and anti-proliferative activity to cancer cells. Robatumumab can be used in osteosarcoma and Ewing sarcoma research[1][2].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Anderson PM, et al. A phase II study of clinical activity of SCH 717454 (robatumumab) in patients with relapsed osteosarcoma and Ewing sarcoma. Pediatr Blood Cancer. 2016 Oct;63(10):1761-70./[2]Wang Y, et al. A fully human insulin-like growth factor-I receptor antibody SCH 717454 (Robatumumab) has antitumor activity as a single agent and in combination with cytotoxics in pediatric tumor xenografts. Mol Cancer Ther. 2010 Feb;9(2):410-8.

CAS Number: 934235-44-6

Molecular Weight: N/A

Compound Purity: 99.90

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: IGF-1R

• SKU: MEXHY-P99218-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99218-10
• Green Labware: No
• Package Unit: 10 mg
• Quantity Unit: STK